Cargando…
COVID-19 and hypopituitarism
Besides the pulmonary manifestations caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can heavily impact on the severity of the syndrome, has been recently associated with coronavirus disease 2019 (COVID-19). Patients with pituitar...
Autores principales: | Frara, Stefano, Loli, Paola, Allora, Agnese, Santini, Chiara, di Filippo, Luigi, Mortini, Pietro, Fleseriu, Maria, Giustina, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363093/ https://www.ncbi.nlm.nih.gov/pubmed/34387832 http://dx.doi.org/10.1007/s11154-021-09672-y |
Ejemplares similares
-
COVID-19 and the pituitary
por: Frara, Stefano, et al.
Publicado: (2021) -
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
por: Giustina, Andrea, et al.
Publicado: (2021) -
Correction: Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
por: Giustina, Andrea, et al.
Publicado: (2021) -
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response
por: di Filippo, Luigi, et al.
Publicado: (2021) -
Low Levels of Vitamin D Are Associated With Markers of Immuno-Inflammatory Response and Clinical Outcome in Covid-19
por: Filippo, Luigi di, et al.
Publicado: (2021)